Epidural Steroid Injection Prior to Spinal Surgery: A Step-Wise and Wise Approach.

dural tear epidural steroid injection esi spinal abscess spinal surgery

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 24 07 2023
accepted: 12 09 2023
medline: 16 10 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: epublish

Résumé

An epidural steroid injection (ESI) is used to treat a number of morbid central nervous system pathologies and is considered a reasonably safe procedure. This study aimed to determine the relative infection risk after spinal surgery by comparing outcomes in spinal surgery patients who received an ESI shortly prior to the surgery against those who did not receive an ESI shortly prior to the surgery. The present study is a retrospective cohort study using a multi-institutional healthcare database, TriNetX, to collect data on patients who received spinal surgery with and without having had ESIs six months before surgery. Two cohorts were generated: Cohort 1 included patients who had received an ESI in the six months prior to spinal surgery, and cohort 2 included patients who did not have an ESI in the six months prior to spinal surgery. The patients in cohort 2 had propensity scores matched 1:1 to those in cohort 1 using common baseline demographics, comorbidities and spinal procedure indications. The spinal procedures and surgeries considered for the analysis included open procedures for any purpose, including exploration, decompression, resection, revision or biopsy. Multiple outcomes were compared across these two cohorts in the three months following the spinal procedure/surgery, including the occurrence of death, surgical site infection, epidural and/or spinal abscess, and dural tear. An ESI in the six months prior to spinal surgery was associated with a significant decrease in the likelihood epidural/spinal abscess in the three months after surgery. There was no change in mortality, wound infection or identification of dural tear in the three months after spinal surgery for those who received an ESI six months before spinal surgery. This data suggests that epidural steroid injections' anti-inflammatory effects provide benefits before surgery beyond symptomatic relief. Given that the degeneration of spinal pathologies is typically advanced rather than corrected by the body's inflammatory response, it is likely that preventing hyperactivation of the body's immune system in the months preceding surgical intervention, a traumatic insult, is protective compared to no intervention and, importantly, without major adverse effects.

Sections du résumé

BACKGROUND BACKGROUND
An epidural steroid injection (ESI) is used to treat a number of morbid central nervous system pathologies and is considered a reasonably safe procedure. This study aimed to determine the relative infection risk after spinal surgery by comparing outcomes in spinal surgery patients who received an ESI shortly prior to the surgery against those who did not receive an ESI shortly prior to the surgery.
METHODS METHODS
The present study is a retrospective cohort study using a multi-institutional healthcare database, TriNetX, to collect data on patients who received spinal surgery with and without having had ESIs six months before surgery. Two cohorts were generated: Cohort 1 included patients who had received an ESI in the six months prior to spinal surgery, and cohort 2 included patients who did not have an ESI in the six months prior to spinal surgery. The patients in cohort 2 had propensity scores matched 1:1 to those in cohort 1 using common baseline demographics, comorbidities and spinal procedure indications. The spinal procedures and surgeries considered for the analysis included open procedures for any purpose, including exploration, decompression, resection, revision or biopsy. Multiple outcomes were compared across these two cohorts in the three months following the spinal procedure/surgery, including the occurrence of death, surgical site infection, epidural and/or spinal abscess, and dural tear.
RESULTS RESULTS
An ESI in the six months prior to spinal surgery was associated with a significant decrease in the likelihood epidural/spinal abscess in the three months after surgery. There was no change in mortality, wound infection or identification of dural tear in the three months after spinal surgery for those who received an ESI six months before spinal surgery.
CONCLUSION CONCLUSIONS
This data suggests that epidural steroid injections' anti-inflammatory effects provide benefits before surgery beyond symptomatic relief. Given that the degeneration of spinal pathologies is typically advanced rather than corrected by the body's inflammatory response, it is likely that preventing hyperactivation of the body's immune system in the months preceding surgical intervention, a traumatic insult, is protective compared to no intervention and, importantly, without major adverse effects.

Identifiants

pubmed: 37842405
doi: 10.7759/cureus.45125
pmc: PMC10569744
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e45125

Informations de copyright

Copyright © 2023, Kozak et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Pain Physician. 2019 Nov;22(6):561-573
pubmed: 31775403
Biology (Basel). 2021 Sep 17;10(9):
pubmed: 34571804
Arthritis Res Ther. 2018 Nov 6;20(1):251
pubmed: 30400975
J Neurosurg Spine. 2017 May;26(5):645-649
pubmed: 28291411
J Clin Diagn Res. 2013 Jan;7(1):93-6
pubmed: 23449755
Spine J. 2016 Feb;16(2):191-6
pubmed: 26235469
Front Pharmacol. 2022 Jul 12;13:956355
pubmed: 35903342
J Clin Diagn Res. 2013 Dec;7(12):2659-60
pubmed: 24551603
J Spine Surg. 2018 Sep;4(3):529-533
pubmed: 30547115
Eur Spine J. 2021 Nov;30(11):3255-3264
pubmed: 33974132
Front Med (Lausanne). 2014 Mar 24;1:7
pubmed: 25705620
Spine J. 2017 Sep;17(9):1209-1214
pubmed: 28428080
Ann Rheum Dis. 1998 Jan;57(1):1-2
pubmed: 9536812
Bone Res. 2021 Jan 29;9(1):7
pubmed: 33514693
Spine (Phila Pa 1976). 2009 Jan 1;34(1):49-59
pubmed: 19127161
Eur Spine J. 2021 Apr;30(4):870-877
pubmed: 32789696
J Neuroinflammation. 2021 Dec 7;18(1):284
pubmed: 34876174
Medicine (Baltimore). 2020 Jul 24;99(30):e21283
pubmed: 32791709
Front Immunol. 2023 Jan 06;13:1084101
pubmed: 36685598
Spine (Phila Pa 1976). 2009 Jun 15;34(14):1441-7
pubmed: 19525834

Auteurs

Michael Kozak (M)

Neurosurgery, Penn State College of Medicine, Hershey, USA.

David R Hallan (DR)

Neurosurgery, Penn State College of Medicine, Hershey, USA.

Elias Rizk (E)

Neurological Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.

Classifications MeSH